
Inxone S 1000mg/500mg Injection
Marketer
Asvins Lifecare
Salt Composition
Ceftriaxone (1000mg) + Sulbactam (500mg)
Overview Inxone S 1000mg/500mg Injection
Combiflox 1000mg/500mg Injection, a dual-action medication, combats diverse bacterial infections. Its mechanism inhibits microbial proliferation, thereby curbing infection spread. Administration must be strictly under a physician's guidance; missed doses should be avoided, and the prescribed treatment cycle completed regardless of symptom improvement. Premature cessation may compromise efficacy. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia. Severe side effects necessitate immediate medical attention. Allergic reactions (rash, pruritus, edema, dyspnea) demand prompt medical help. Inform your doctor of all current medications before commencing treatment. Pregnant or lactating individuals should consult their physician prior to use. Alcohol consumption should be avoided due to potential increased drowsiness. While generally not impairing driving ability, avoid driving if experiencing somnolence or dizziness. Adequate rest, balanced nutrition, and sufficient hydration are crucial for optimal recovery. Follow-up laboratory tests may be conducted to monitor treatment efficacy.
Primary Ingredients of Inxone S 1000mg/500mg Injection
No text provided to rephrase.
Uses of Inxone S 1000mg/500mg Injection
Infections caused by bacteria
Major Benefits of Inxone S 1000mg/500mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Inxone S 1000mg/500mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Inxone S 1000mg/500mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Inxone S 1000mg/500mg Injection works:
Inxone S Injection, containing 1000mg of Ceftriaxone and 500mg of Sulbactam, employs a dual-drug approach to combat bacterial infections. Ceftriaxone, a potent antibiotic, disrupts bacterial cell wall synthesis, thereby hindering bacterial growth and survival. Sulbactam, a beta-lactamase inhibitor, counteracts bacterial resistance mechanisms, optimizing Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no reported adverse reactions from concurrent use of Inxone S 1000mg/500mg Injection and alcohol.
PregnancySAFE IF PRESCRIBED
The injectable medication Inxone S (1000mg/500mg) is typically deemed safe for use during gestation. Preclinical trials in animals revealed minimal or absent harm to the fetus; nevertheless, data from human trials remain scarce.
Breast feedingCAUTION
Administering Inxone S 1000mg/500mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
The administration of Inxone S 1000mg/500mg Injection can potentially reduce attentiveness, impair visual acuity, and induce drowsiness or dizziness. Driving should be avoided if any of these effects manifest.
KidneyCONSULT YOUR DOCTOR
Data regarding the administration of Inxone S 1000mg/500mg Injection to individuals with renal impairment is scarce. Physician consultation is advised.
LiverCAUTION
The Inxone S 1000mg/500mg Injection requires careful administration in individuals with severe hepatic impairment; dosage modification may be necessary. Medical advice is recommended. Dosage alteration for Inxone S 1000mg/500mg Injection is unnecessary for patients exhibiting mild to moderate liver dysfunction.
What if you forget to take Inxone S 1000mg/500mg Injection :
Should you forget a scheduled Inxone S 1000mg/500mg Injection, seek medical advice.
Facts to Know About Inxone S 1000mg/500mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
